300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Gibraltar
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Finland (September 2026)

The most active venture capital funds investing in Finland Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Finland Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Business Finland
VC Fund
9 Finland, United States, Sweden Grant, Seed, Debt Financing Software, SaaS, Biotechnology $50k–$10M
Lifeline Ventures
VC Fund
7 Finland, United States, United Kingdom Seed, Series A, Venture - Series Unknown Software, Health Care, Artificial Intelligence $580k–$22M
Finnvera Venture Capital
VC Fund
7 Finland, United States, Chile Seed, Series A Software, Health Care, Manufacturing $250k–$23M
Voima Ventures
VC Fund
6 Finland, Sweden, Norway Seed, Pre-Seed, Series A Biotechnology, Health Care, Artificial Intelligence $464k–$30M
Innovestor
VC Fund
5 Finland, Sweden, Denmark Seed, Venture - Series Unknown, Pre-Seed Software, Health Care, Information Technology $204k–$5.8M
Maki.vc
VC Fund
4 Finland, Norway, Denmark Seed, Series A, Pre-Seed Software, E-Commerce, Information Technology $578k–$37M
Icebreaker.vc
VC Fund
4 Finland, Sweden, Estonia Pre-Seed, Seed, Series A Software, Information Technology, Artificial Intelligence $110k–$25M
Springvest
VC Fund
3 Finland Series A, Venture - Series Unknown, Seed Biotechnology, Health Care, Medical $1.6M–$53M
Butterfly Ventures
VC Fund
3 Finland, Sweden, Norway Seed, Pre-Seed Software, Health Care, Information Technology $110k–$4.3M
StartUp Health
VC Fund
3 United States, Canada, United Kingdom Seed, Pre-Seed Health Care, Wellness, Medical $20k–$4M
Reaktor Ventures
VC Fund
3 Finland, Germany, United States Seed, Pre-Seed, Series A Software, Internet, E-Commerce $127k–$6.8M
Nordic Science Investments
VC Fund
3 Finland, Sweden, United States Seed, Pre-Seed, Series A Biotechnology, Medical, Health Diagnostics $373k–$4.6M
Karolinska
VC Fund
3 Sweden, Denmark, United States Venture - Series Unknown, Seed Biotechnology, Health Care, Pharmaceutical $4.7M–$6.9M
M Ventures
VC Fund
3 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Novartis Venture Fund
VC Fund
3 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$120M
Metsola Ventures
VC Fund
2 Finland Series A, Pre-Seed Medical, mHealth, Automotive $2.2M–$5.4M
Novo Holdings
VC Fund
2 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
Tesi
VC Fund
2 Finland, United States, Switzerland Series A, Series B Software, Manufacturing, Health Care $2.4M–$46M
Vesalius Biocapital Partners
VC Fund
2 Belgium, Germany, France Series A, Series B, Series C Biotechnology, Health Care, Medical $3.9M–$100M
Inventure
VC Fund
2 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Health Care $549k–$25M
Samsung Venture Investment
VC Fund
2 South Korea, United States, India Series A, Series B, Seed Information Technology, Software, Health Care $83k–$25M
Nuard Ventures
VC Fund
2 Finland, Germany, United States Seed, Angel, Pre-Seed IaaS, Video, Fashion $159k–$680k
University of Helsinki
VC Fund
2 Finland, Luxembourg, United States Seed, Pre-Seed, Series A Medical, Health Care, Biotechnology $54k–$7.4M
Cascara Ventures
VC Fund
2 Germany, Finland, The Netherlands Series A, Seed, Series B Health Care, Biotechnology, Medical Device $2M–$7.9M
Sandwater
VC Fund
2 Norway, Germany, France Series A, Seed AgTech, Medical, Agriculture $8.5M–$24M
Metaplanet
VC Fund
1 United States, United Kingdom, Estonia Seed, Series A, Series B Artificial Intelligence, Software, Health Care $1.7M–$62M
Torrey Pines Investment
VC Fund
1 United States, Russian Federation, The Netherlands Seed, Pre-Seed Biotechnology, Health Care, Pharmaceutical $3M–$3.1M
Sunstone Life Science Ventures
VC Fund
1 Denmark, Sweden, Switzerland Series A, Series B Biotechnology, Health Care, Medical $5.5M–$61M
SHS Capital
VC Fund
1 Germany, Switzerland, France Venture - Series Unknown, Series B Health Care, Medical Device, Medical $4.9M–$60M
Korpun Siemen
VC Fund
1 Finland Seed, Venture - Series Unknown, Angel Software, Marketing, Information Technology $480k–$1.3M
Lynx Capital
VC Fund
1 Finland, United States Series A, Venture - Series Unknown, Seed Health Care, Medical, Biotechnology
J12
VC Fund
1 Sweden, Norway, Germany Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $974k–$30M
Gaingels
VC Fund
1 United States, Canada, Mexico Seed, Series A, Series B Software, Health Care, Artificial Intelligence $1M–$100M
Way to Wellville
VC Fund
1 United States, Finland Series B, Venture - Series Unknown, Series A Software, Medical, Health Care $1.5M–$15M
Unifund
VC Fund
1 Finland Seed, Venture - Series Unknown Medical, Software, Biopharma
Visionplus
VC Fund
1 Finland, United States, United Kingdom Seed, Venture - Series Unknown, Series A Software, Information Technology, Internet $83k–$14M
DigiTx Partners
VC Fund
1 United States, Canada, Finland Series A, Seed, Series B Health Care, Artificial Intelligence, Medical $2.7M–$43M
Noaber
VC Fund
1 The Netherlands, Israel, Germany Seed, Series A, Pre-Seed Health Care, Medical, Fitness $423k–$20M
Inveni Capital
VC Fund
1 Finland, United Kingdom Medical, Health Care, Biotechnology
ENEA Tech e Biomedical
VC Fund
1 Italy, Finland Venture - Series Unknown, Series A, Grant Health Care, Biotechnology, Medical Device $530k–$21M
XR Invest
VC Fund
1 Finland, United States Series A, Series B, Series C Medical Device, Sensor, Medical
Ascend Capital Partners
VC Fund
1 Finland, Israel, Austria Series A, Seed, Series B Health Care, Software, Medical Device $1.5M–$12M
HTGF (High-Tech Gruenderfonds)
VC Fund
1 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $850k–$31M
MVM Life Science Partners
VC Fund
1 United States, United Kingdom, Switzerland Series B, Series C Health Care, Biotechnology, Medical
Freeman Road
VC Fund
1 Finland Venture - Series Unknown Medical, Health Care, Therapeutics
Force 10 Partners
VC Fund
1 Finland Seed Medical, Health Care, Biotechnology
Indaco Venture Partners
VC Fund
1 Italy, United Kingdom, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Life Science $3.5M–$110M
CDP Venture Capital
VC Fund
1 Italy, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $483k–$23M
Cor Group
VC Fund
1 Finland Seed, Pre-Seed, Series A Health Care, Medical, Biotechnology $2.3M–$8.7M
Ananda Impact Ventures
VC Fund
1 Germany, United Kingdom, Finland Seed, Series A, Series B Health Care, Software, Information Technology $1.6M–$53M
Access all 105 VC funds in Finland Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Business Finland
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in Finland Medical startups, 17 in the past 12 months

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Grant, Seed, Debt Financing
  • Geography: Finland, United States, Sweden

Investor stats

  • Total investments: 235
  • Round size: Seed $334k–$3.5M; Grant $50k–$10M; Debt Financing $241k–$6.5M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
  • Coolbrook — Our RotoDynamic electric technology can cut 30% of industrial emissions annually, delivering hope at industrial scale.
  • Solar Foods — Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes.
Show all investments...

Lifeline Ventures
VC Fund · Helsinki, Southern Finland, Finland · 7 investments in Finland Medical startups

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 201
  • Round size: Seed $580k–$5.4M; Series A $2.8M–$22M; Venture - Series Unknown $616k–$17M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely actively investing — fresh fund, raised $464M in 2025

Portfolio highlights

  • S-Transistors — S-Transistors is one of the few businesses founded on a truly novel core technology that has the potential to serve as an enabling layer for a whole industry.
  • Thor Dynamics — Directed Energy Systems for Counter-Drone Defense
  • Everywear Games — Everywear Games is the world’s leading wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s gamesare consistently on top of global charts.
Show all investments...

Finnvera Venture Capital
VC Fund · Kuopio, Eastern Finland, Finland · 7 investments in Finland Medical startups

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: Finland, United States, Chile

Investor stats

  • Total investments: 95
  • Round size: Seed $250k–$2.3M; Series A $1.8M–$23M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
  • eMabler — EMabler is an EV charging infrastructure software company that develops an API-first platform used by businesses to operate, manage, and scale electric vehicle charging networks. It provides a centralized system for charge point management, billing, pricing, roaming, and energy optimization, allowing operators to control large networks of EVchargers from a single platform. The software connects charging hardware with business systems such as CRM, payment, and energy management tools through open APIs and a large library of integrations. The company focuses on enabling enterprises, such as energy utilities, parking operators, and retail businesses, to embed EV charging directly into their existing services and digital platforms rather than building standalone charging systems. This includes white-label solutions where charging is integrated into a company’s own app or customer experience under its brand.
  • CHAOS — At CHAOS, we strive to democratize data and harness the power of AI and cutting-edge technology, delivering transformative location insights that empower decision-makers to design more liveable cities- sustainable, human-centered where the quality-of-life soars.
Show all investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 6 investments in Finland Medical startups, 6 in the past 12 months

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 61
  • Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: Likely still investing — raised $108M in 2023

Portfolio highlights

  • Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
  • TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
  • Photoncycle — The year-round solar energy system for heating and electricity
Show all investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 5 investments in Finland Medical startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 93
  • Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.8M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely still investing — raised $33M in 2023

Portfolio highlights

  • STRGY AI — The strategy was never the problem. The evidence was correct, sitting in someone's hands, and it died anyway because nothing in the organization was built to carry that evidence from where it was seen to where it could be acted on, and keep it alive long enough to matter. Not a bad plan. Not bad people. A structural gap between signal andauthority that every existing tool — decks, dashboards, status meetings — is too static and too easy to ignore to actually close.STRGY exists because that gap is the default state of every organization above a certain size, and closing it has always required either a heroic individual repeating themselves for years or luck (the corporate pilot needed one person to remember "do not drop this" at the right moment, and no one did). That's not a strategy problem to solve with a better framework — it's an infrastructure problem. You need something that holds the signal, doesn't forget it, doesn't get bored repeating it, and resurfaces it automatically the moment the gap between evidence and action starts to widen. That's what a human can't do reliably at scale, and what software with real memory can.
  • Amplifiles — Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams.
  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Show all investments...

Maki.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Medical startups, 6 in the past 12 months

We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Finland, Norway, Denmark

Investor stats

  • Total investments: 103
  • Round size: Seed $948k–$8.3M; Pre-Seed $578k–$2.7M; Series A $3.5M–$37M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely actively investing — fresh fund, raised $106M in 2024

Portfolio highlights

  • Aavuus — Aavuus is building a global network of ground-based laser stations to detect and track space debris with high precision.
  • Metaktik — Tactical Metasurface Antenna Solution for Defence. Ultralight Antennas for Satellites.
  • Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
Show all investments...

Icebreaker.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Medical startups

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Finland, Sweden, Estonia

Investor stats

  • Total investments: 142
  • Round size: Seed $409k–$5.4M; Pre-Seed $110k–$1.2M; Series A $3.1M–$25M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — raised $24M in 2021

Portfolio highlights

  • Cytely — Cytely operationalizes biological measurement, turning microscopy into standardized, reproducible data so research teams can accelerate discovery.
  • Oplane — Connect your repo. See and fix your vulnerabilities in minutes. AI-powered threat modeling - no consultants, no weeks of docs.
  • ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
Show all investments...

Springvest
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Medical startups

The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Finland

Investor stats

  • Total investments: 23
  • Round size: Seed $1.6M–$7.6M; Series A $3.6M–$53M; Venture - Series Unknown $4.7M–$29M
  • Lead/follow: 74% lead, 26% follow

Portfolio highlights

  • ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
  • MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Show all investments...

Butterfly Ventures
VC Fund · Oulu, Oulu, Finland · 3 investments in Finland Medical startups

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 91
  • Round size: Seed $224k–$2.1M; Pre-Seed $110k–$4.3M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $49M in 2022

Portfolio highlights

  • DREV — DREV is a cleantech company manufacturing contamination control solutions for the world’s most advanced manufacturing facilities.
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 3 investments in Finland Medical startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Wellness, Medical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 315
  • Round size: Seed $100k–$4M; Pre-Seed $20k–$854k
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2018

Portfolio highlights

  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Reaktor Ventures
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Medical startups

Reaktor Ventures they invest in seed stage companies and helps them to create markets.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Germany, United States

Investor stats

  • Total investments: 60
  • Round size: Seed $127k–$2.1M; Pre-Seed $158k–$1.8M; Series A $1.7M–$6.8M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • allies.digital — Allies is a match-making platform curating businesses with IT-, digital and creative agencies. No more miss-matches when buying IT & creative services.
  • StarBerry Games — StarBerry Games GmbH is a mobile games company based in Berlin, Germany. The company develops free-to-play casual mobile games and is best known for its games Merge Mayor and Idle Coffee Corp.
Show all investments...

Nordic Science Investments
VC Fund · 3 investments in Finland Medical startups

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 17
  • Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
  • Lead/follow: 88% lead, 12% follow
  • Last fund: Likely still investing — raised $34M in 2024

Portfolio highlights

  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
  • Perfat Technologies — Perfect fats for better foods.
Show all investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 3 investments in Finland Medical startups

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Venture - Series Unknown, Seed
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 32
  • Round size: Venture - Series Unknown $4.7M–$6.9M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
  • Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Finland Medical startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 186
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $15M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
  • Remepy — Redefining combination therapy by fusing traditional pharmaceuticals with clinically validated app-delivered protocols in a single, regulated prescription.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Finland Medical startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 230
  • Round size: Series A $5.1M–$85M; Series B $11M–$120M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

Metsola Ventures
VC Fund · Espoo, Southern Finland, Finland · 2 investments in Finland Medical startups

Metsola Ventures

Show more...

Investment focus

  • Industry: Medical, mHealth, Automotive
  • Stage:Series A, Pre-Seed
  • Geography: Finland

Investor stats

  • Total investments: 3
  • Round size: Series A $2.2M–$5.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • RoadCloud — Use the worlds most accurate road condition data to your advantage. Real-time hyperlocal road weather data from your road network 24/7.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 2 investments in Finland Medical startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 395
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • PTC Therapeutics — Translating Science. Transforming Lives.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Show all investments...

Tesi
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Series A, Series B
  • Geography: Finland, United States, Switzerland

Investor stats

  • Total investments: 152
  • Round size: Series A $2.4M–$46M; Series B $3.1M–$37M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $177M in 2017

Portfolio highlights

  • ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
  • Vexlum — A #laser company providing high-power #VECSELs for #QuantumTechnology
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Show all investments...

Vesalius Biocapital Partners
VC Fund · Strassen, Luxembourg, Luxembourg · 2 investments in Finland Medical startups

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, Germany, France

Investor stats

  • Total investments: 61
  • Round size: Series A $3.9M–$20M; Series B $4.4M–$26M; Series C $7M–$100M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $103M in 2023

Portfolio highlights

  • Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
  • ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Show all investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 178
  • Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $140M in 2022

Portfolio highlights

  • Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
  • UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Samsung Venture Investment
VC Fund · Seocho, Seoul-t'ukpyolsi, South Korea · 2 investments in Finland Medical startups, 8 in the past 12 months

Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 140
  • Round size: Seed $83k–$4.1M; Series A $1.7M–$25M; Series B $3M–$23M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • N.THING — Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with massproductivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. .CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place.SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience.Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere.Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media.Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions
Show all investments...

Nuard Ventures
VC Fund · 2 investments in Finland Medical startups

Nuard Ventures invests in innovative early stage companies.

Show more...

Investment focus

  • Industry: IaaS, Video, Fashion
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Finland, Germany, United States

Investor stats

  • Total investments: 8
  • Round size: Seed $159k–$680k
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
  • MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
  • Polka Dot Studio — Kalian Bisa Memasang Taruhan Online Dengan Sangat Mudah Dan Nyaman Di Situs DEWAHOKI Yang Sudah Resmi Di Indonesia
Show all investments...

University of Helsinki
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Medical startups

The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Luxembourg, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $54k–$7.4M; Pre-Seed $837k–$1.2M; Series A $2.9M–$3.9M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Ferrivia — Ferrivia Oy is a Finnish health-tech startup specializes in digital health services and personalized tracking for iron deficiency and low ferritin levels.
  • MultivisionDx — MultivisionDx's computer vision technology integrates the tumor's unique biological and geographical properties, as well as its milieu, to generate patient-specific tumor profiles.
  • Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Show all investments...

Cascara Ventures
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Finland Medical startups

96 Normal 0 false false false EN-GB X-NONE X-NONE

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Finland, The Netherlands

Investor stats

  • Total investments: 13
  • Round size: Series A $2M–$7.9M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Fiagon — Fiagon develops clinical navigation systems that reimagine image guidance by improving the function of electromagnetic navigation. Fiagon's systems use electromagnetic tracking matrix algorithms and flexible pointer technology that indicates the position of the instrument used in the CT or MRI image data, allowing physicians to get accurateplanning, improve patient outcomes, and implementation of the operation.
  • Meidrix Biomedicals — Meidrix Biomedicals is a medical biotechnology company that specializes in medical devices for cartilage repair. Meidrix Biomedicals also offers regenerative and biological medical products. Meidrix Biomedicals was founded in 2009 and was headquartered in Bayern, Germany.
  • SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
Show all investments...

Sandwater
VC Fund · Oslo, Oslo, Norway · 2 investments in Finland Medical startups

We are Sandwater. Regeneration of our resources. Vitalizing healthcare & education. Improving life through technology.

Show more...

Investment focus

  • Industry: AgTech, Medical, Agriculture
  • Stage:Series A, Seed
  • Geography: Norway, Germany, France

Investor stats

  • Total investments: 24
  • Round size: Series A $8.5M–$24M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Mantle8 — Using bottom-up exploration and decades of geology experience, we are on a mission to deliver natural hydrogen to the world.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
  • Alva Industries — Serving industries from aerospace to marine, we deliver high-performance, sustainable motors to drive a cleaner, more efficient future.
Show all investments...

Metaplanet
VC Fund · Tallinn, Harjumaa, Estonia · 1 investments in Finland Medical startups

an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Estonia

Investor stats

  • Total investments: 110
  • Round size: Seed $1.7M–$12M; Series A $5.9M–$40M; Series B $23M–$62M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: Likely actively investing — fresh fund, raised $69M in 2025

Portfolio highlights

  • Kopra Bio — Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
  • Inherent — Recursively self-improving to discover new knowledge.
  • Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Show all investments...

Torrey Pines Investment
VC Fund · San Diego, California, United States · 1 investments in Finland Medical startups

Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Pre-Seed
  • Geography: United States, Russian Federation, The Netherlands

Investor stats

  • Total investments: 32
  • Round size: Seed $3M–$3.1M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $60M in 2017

Portfolio highlights

  • Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
  • BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
  • MAIR PHARMACEUTICALS — Mair Pharmaceutical creates innovative processes and produces well-known unique substances for pharmaceutical and biopharmaceutical firms worldwide.
Show all investments...

Sunstone Life Science Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Finland Medical startups

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Denmark, Sweden, Switzerland

Investor stats

  • Total investments: 63
  • Round size: Series A $5.5M–$61M; Series B $9.6M–$58M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2019

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

SHS Capital
VC Fund · Tübingen, Baden-Wurttemberg, Germany · 1 investments in Finland Medical startups

SHS is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Venture - Series Unknown, Series B
  • Geography: Germany, Switzerland, France

Investor stats

  • Total investments: 44
  • Round size: Series B $4.9M–$60M; Venture - Series Unknown $6.6M–$21M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: Likely still investing — raised $273M in 2022

Portfolio highlights

  • Arzneimittelwerk Warngau — Unsere Schwerpunkte Karriere bei AMW
  • ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
  • Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
Show all investments...

Korpun Siemen
VC Fund · Oulu, Oulu, Finland · 1 investments in Finland Medical startups

Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.

Show more...

Investment focus

  • Industry: Software, Marketing, Information Technology
  • Stage:Seed, Venture - Series Unknown, Angel
  • Geography: Finland

Investor stats

  • Total investments: 10
  • Round size: Seed $480k–$1.3M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
  • Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
  • Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lynx Capital
VC Fund · Shanghai, Shanghai, China · 1 investments in Finland Medical startups

cross-border, healthcare, life science, investment, VC, China, US

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Venture - Series Unknown, Seed
  • Geography: Finland, United States

Investor stats

  • Total investments: 5
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Marginum — Pioneering the next-generation quantitative surgical techniques.
  • Elucida Oncology — Elucida Oncology focuses on transforming outcomes for patients with primary solid tumors and metastatic cancer. The company utilizes the novel target or clear capabilities of its ultra-small C-Dot cancer-targeting particle platform across diagnostic imaging, surgical, and a wide range of therapeutic applications.
  • Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
Show all investments...

J12
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Finland Medical startups

J12 is a thesis-driven venture capital firm partnering early with technical founders across Europe to build category-defining data and AI companies across infrastructure, tooling, and domain-specific applications

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Sweden, Norway, Germany

Investor stats

  • Total investments: 63
  • Round size: Seed $1.1M–$8M; Pre-Seed $974k–$4.1M; Series A $7M–$30M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Camphouse — Mediatool is the all-in-one planning, execution, tracking and reporting tool for media and marketing campaigns. Increase productivity with streamlined delivery and better collaboration across all your marketing activities. Grow revenue with confidence, using real-time performance data to optimise investment.Hundreds of tangible benefits, onebetter way of working. Forget spreadsheets and get to know Mediatool.
  • Volve — Volve turns tender and contract documents into a structured baseline, helping construction teams catch risk, run compliance checks, and win better bids with AI.
  • Galdera Labs — Disposable financial models cost more than time. They cost context. Galdera was built for growth finance teams looking to save both.
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 1 investments in Finland Medical startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 1335
  • Round size: Seed $1M–$8.2M; Series A $5M–$35M; Series B $16M–$100M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fresh fund, raised $140k in 2026

Portfolio highlights

  • Epirus — Epirus is a high-growth technology company that develops cutting-edge directed energy systems and power management solutions to transform multiple industries.
  • BQP — At BQP, we’re developing a quantum-accelerated digital twin platform for mission-critical applications. The platform, BQPhy, is a back-end engine that integrates seamlessly into existing engineering workflows and operates on today’s infrastructure without requiring quantum hardware. BQPhy helps teams solve large-scale, complex challenges inengineering optimization, data-driven modeling (ML), and physics-based (CFD) simulations. We are bridging the gap between current high-performance computers and future quantum systems with probabilistic algorithms from quantum information science, unlocking simulation capabilities that were previously impractical or impossible. BQPhy reduces time, accuracy, and throughput inefficiencies, thereby accelerating development cycles, unlocking previously unexplored design spaces, lowering costs, and enhancing product outcomes.
  • Sharper Sense — Neuromodulation for Clear Senses
Show all investments...

Way to Wellville
VC Fund · Astoria, Oregon, United States · 1 investments in Finland Medical startups

Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.

Show more...

Investment focus

  • Industry: Software, Medical, Health Care
  • Stage:Series B, Venture - Series Unknown, Series A
  • Geography: United States, Finland

Investor stats

  • Total investments: 7
  • Round size: Series B $12M–$15M; Venture - Series Unknown $1.5M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Upbeat — Upbeat will be your PR partner for a fraction of the cost of traditional PR firms. Through our software and expertise, we will help you develop a media
  • Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
Show all investments...

Unifund
VC Fund · 1 investments in Finland Medical startups

Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.

Show more...

Investment focus

  • Industry: Medical, Software, Biopharma
  • Stage:Seed, Venture - Series Unknown
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
  • PrecisionPhage — PrecisionPhage Ltd. is a Finland-based biotech company specialized in bacteriophage technologies. Join Phagenomics: https://t.co/R9NxBAecv5
Show all investments...

Visionplus
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Medical startups

WE HELP YOU TO GROW FASTER!

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 74
  • Round size: Seed $83k–$1.3M; Series A $2M–$14M; Venture - Series Unknown $100k–$4M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Moppi.com — Moppi.com is an online marketplace that connects professional cleaners with customers. The marketplace plays host to cleaners that are certified and insured by the company, and uses only approved cleaning equipment and detergents. Moppi.com was launched by Matti Tiainen in January 2015 and is operated from Helsinki, Finland.
  • Hooplo Footy — The company's business area is the development and sale of online games and all other legitimate business.
  • Film Finances — Discover Film Finances Inc., the global leader in film completion guarantees, ensuring on-schedule and on-budget delivery for over seven decades. Explore our services and industry expertise.
Show all investments...

DigiTx Partners
VC Fund · Brisbane, California, United States · 1 investments in Finland Medical startups

At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcareecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical
  • Stage:Series A, Seed, Series B
  • Geography: United States, Canada, Finland

Investor stats

  • Total investments: 32
  • Round size: Seed $2.7M–$7.8M; Series A $5M–$23M; Series B $6M–$43M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2018

Portfolio highlights

  • Neon Health — Neon accelerates patient access to critical care by jumping through all the hoops to onboard and adhere to life-saving drugs, treatments.
  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
  • Auxira Health — Auxira Health is committed to providing virtual practice extensions that seem like a natural extension of your team, bringing order to the chaos of modern healthcare.
Show all investments...

Noaber
VC Fund · Lunteren, Gelderland, The Netherlands · 1 investments in Finland Medical startups

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Show more...

Investment focus

  • Industry: Health Care, Medical, Fitness
  • Stage:Seed, Series A, Pre-Seed
  • Geography: The Netherlands, Israel, Germany

Investor stats

  • Total investments: 20
  • Round size: Seed $423k–$6.3M; Series A $3M–$20M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
  • Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Show all investments...

Inveni Capital
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Medical startups

Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Geography: Finland, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
  • Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.
Show all investments...

ENEA Tech e Biomedical
VC Fund · Rome, Lazio, Italy · 1 investments in Finland Medical startups

ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Venture - Series Unknown, Series A, Grant
  • Geography: Italy, Finland

Investor stats

  • Total investments: 13
  • Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
  • Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
  • Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
XR Invest
VC Fund · 1 investments in Finland Medical startups

XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.

Show more...

Investment focus

  • Industry: Medical Device, Sensor, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Finland, United States

Investor stats

  • Total investments: 4
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Ascend Capital Partners
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Finland Medical startups

Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: Finland, Israel, Austria

Investor stats

  • Total investments: 19
  • Round size: Seed $1.5M–$9.3M; Series A $2.4M–$12M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • DriveU.auto — Transform existing terminal tractors into autonomous vehicles. Fast ROI. Continuous operation in mixed traffic.
  • Pionix — PIONIX develops EVerest, a fully featured commercial open source SW platform for charging stations. With our open platform, we will provide a broad ecosystem for EV charging that can be easily extended by the open-source community and utilized by any commercial party.PIONIX as main developer of the EVerest ecosystem offers integration andsoftware update services, cloud operations and productivity & security enhancements as subscriptions.
  • piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 1 investments in Finland Medical startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 713
  • Round size: Seed $850k–$6.9M; Series A $3.1M–$31M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $515M in 2022

Portfolio highlights

  • Coredinate — COREDINATE is a fully integrated, professional and innovative solution for security companies, maintenance companies and care providers that helps optimize your processes, help you maintain your quality, and help you satisfy your customers. Whether it's control system, tour planning, task management or event capture: COREDINATE security ,maintenance or maintenance automates all your daily tasks and optimizes monitoring
  • BlueID GmbH — Smart locks for professionals. BlueID delivers flexible, secure and convenient smart locks for all doors in and around your office.
  • OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Show all investments...

MVM Life Science Partners
VC Fund · London, England, United Kingdom · 1 investments in Finland Medical startups

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series C
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 71
  • Lead/follow: no public data

Portfolio highlights

  • Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
  • Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
Show all investments...

Freeman Road
VC Fund · 1 investments in Finland Medical startups

Freeman Road is a boutique investment and development company focused on strategic early stage opportunities.

Show more...

Investment focus

  • Industry: Medical, Health Care, Therapeutics
  • Stage:Venture - Series Unknown
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Valo Therapeutics — Valo Therapeutics is an immunotherapy company that is developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The Valo Tx platform, PeptiCRAd (Peptide-coated Conditionally Replicating Adenovirus), was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. It turns oncolytic adenovirusesinto targeted tissue specific cancer vaccines without the need to generate and manufacture multiple genetically modified viruses. The company is also developing PeptiENV, among other neoantigen strategies, in collaboration with Professor Cerullo. PeptiENV is expected to improve the therapeutic response to enveloped oncolytic viruses in the treatment of multiple forms of cancer.
Show all investments...

Force 10 Partners
VC Fund · Irvine, California, United States · 1 investments in Finland Medical startups

Force 10 Partners is an advisory firm with deep domain knowledge in financial and operational corporate restructuring,

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • RNatives — RNatives specializes in the field of biotechnology, focusing on the development of innovative RNA-based therapies. The company's expertise lies in RNA activation, particularly targeting VEGFA for the treatment of cardiovascular diseases. RNatives is dedicated to advancing its lead programs through rigorous research and development, aiming tooffer novel therapeutic options for conditions with unmet medical needs. With a team of skilled professionals, RNatives is committed to pushing the boundaries of biotechnology to improve patient outcomes.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 1 investments in Finland Medical startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B, Series C
  • Geography: Italy, United Kingdom, Switzerland

Investor stats

  • Total investments: 48
  • Round size: Series A $3.5M–$33M; Series B $8.9M–$89M; Series C $18M–$110M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $302M in 2018

Portfolio highlights

  • Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
  • Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Show all investments...

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 1 investments in Finland Medical startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 295
  • Round size: Seed $483k–$7.7M; Series A $3.3M–$23M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $197M in 2021

Portfolio highlights

  • Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
  • Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
  • ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
Show all investments...

Cor Group
VC Fund · Oulu, Oulu, Finland · 1 investments in Finland Medical startups

Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland

Investor stats

  • Total investments: 6
  • Round size: Seed $2.3M–$8.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Gosta Labs — Focus on care
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Nightingale Health — The most advanced health check for the health industry.
Show all investments...

Ananda Impact Ventures
VC Fund · Munich, Bayern, Germany · 1 investments in Finland Medical startups

We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Germany, United Kingdom, Finland

Investor stats

  • Total investments: 72
  • Round size: Seed $1.6M–$18M; Series A $3.9M–$17M; Series B $7.3M–$53M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fresh fund, raised $85M in 2026

Portfolio highlights

  • AIRMO — AIRMO is supporting the direct emitters, decision makers and financial institutions to efficiently transition to Net-0 by monitoring their direct emissions from space. With our roots in innovation and a commitment to environmental responsibility, we aim to revolutionize GHG monitoring through advanced satellite technology, proprietary LiDARinstrument and data analytics. We exist to monitor and manage humanity's impact on Earth.
  • Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.
  • Entelo Bio — Precision Medicine
Show all investments...

Medical VC funding in Finland at a glance

Stats across 122 deals from 105 investors.

105
investors
in Finland Medical startups
122
deals
in Finland Medical startups
$2.2M
median round
in Finland Medical startups
52%
lead investors
lead at least one round
27%
Seed
most common funding stage

Access all 105 VC funds in Finland Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 105 VC funds investing in Finland Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists